The course of metastatic prostate cancer under treatment


Demir A., Cecen K., Karadag M. A. , Kocaaslan R., Turkeri L.

SPRINGERPLUS, vol.3, 2014 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 3
  • Publication Date: 2014
  • Doi Number: 10.1186/2193-1801-3-725
  • Title of Journal : SPRINGERPLUS

Abstract

The first-line management of metastatic prostate cancer is hormonal therapy. However, resistance to this treatment will emerge within an average of 24 months. Our purpose was to determine the course of metastatic prostate cancer under treatment.